Annexin Pharmaceuticals AB (publ)
556960-9539ActiveClinical stage biotech developing ANXV for eye diseases and cancer.
Biotechnology Companyannexinpharma.com
Yleiskatsaus
- 1–4
- Työntekijät
- ≤1t SEK
- Liikevaihto
- 2014
- Perustettu
Avainpäättäjät
Anders Haegerstrand
Chief Executive Officer
@annexinpharma.com+46705XXXXXX
Susanne Andersson
Chief Financial Officer
@annexinpharma.com+46730XXXXXX
Mikael Lönn
Member of the Board
@annexinpharma.com
Carl-Fredrik Lindner
Member of the Board
@annexinpharma.com
+5 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Annexin Pharmaceuticals is an innovative, clinical-stage biotechnology company based in Stockholm, Sweden, established in 2014. The company is recognized as a world-leader in the research and application of Annexin A5 biology. Their primary focus is the development of the investigational drug candid...